Lenacapavir: a giant step forward in HIV prevention-but a missed opportunity for achieving equity and access.
Publication
, Journal Article
Yamey, G; Machingaidze, S
Published in: BMJ (Clinical research ed.)
October 2024
Duke Scholars
Published In
BMJ (Clinical research ed.)
DOI
EISSN
1756-1833
ISSN
0959-8138
Publication Date
October 2024
Volume
387
Start / End Page
q2254
Related Subject Headings
- Quinolones
- Pre-Exposure Prophylaxis
- Humans
- Health Services Accessibility
- Health Equity
- HIV Infections
- General & Internal Medicine
- Anti-HIV Agents
- 52 Psychology
- 42 Health sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Yamey, G., & Machingaidze, S. (2024). Lenacapavir: a giant step forward in HIV prevention-but a missed opportunity for achieving equity and access. BMJ (Clinical Research Ed.), 387, q2254. https://doi.org/10.1136/bmj.q2254
Yamey, Gavin, and Shingai Machingaidze. “Lenacapavir: a giant step forward in HIV prevention-but a missed opportunity for achieving equity and access.” BMJ (Clinical Research Ed.) 387 (October 2024): q2254. https://doi.org/10.1136/bmj.q2254.
Yamey G, Machingaidze S. Lenacapavir: a giant step forward in HIV prevention-but a missed opportunity for achieving equity and access. BMJ (Clinical research ed). 2024 Oct;387:q2254.
Yamey, Gavin, and Shingai Machingaidze. “Lenacapavir: a giant step forward in HIV prevention-but a missed opportunity for achieving equity and access.” BMJ (Clinical Research Ed.), vol. 387, Oct. 2024, p. q2254. Epmc, doi:10.1136/bmj.q2254.
Yamey G, Machingaidze S. Lenacapavir: a giant step forward in HIV prevention-but a missed opportunity for achieving equity and access. BMJ (Clinical research ed). 2024 Oct;387:q2254.
Published In
BMJ (Clinical research ed.)
DOI
EISSN
1756-1833
ISSN
0959-8138
Publication Date
October 2024
Volume
387
Start / End Page
q2254
Related Subject Headings
- Quinolones
- Pre-Exposure Prophylaxis
- Humans
- Health Services Accessibility
- Health Equity
- HIV Infections
- General & Internal Medicine
- Anti-HIV Agents
- 52 Psychology
- 42 Health sciences